Nephrocare Health Services Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nephrocare Health Services Limited has submitted its financial results to NSE for the quarter and nine months ended December 31, 2025. This is a standard regulatory filing under listing obligations, confirming the company has met its periodic disclosure requirement. The actual financial figures, including revenue, profit after tax, and margins, are not contained in this filing text and would be available in the detailed results document.
No direct price impact from this submission notice itself. Investors should review the detailed results document for actual revenue, profit, and margin performance to assess the company's Q3 FY26 trajectory.